Drugs / Optive Fusion®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06221345 Comparator | Dec 2021 → Jul 2023 | cataract, dry eye syndrome | Chang Gung Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Optive Fusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06221345 ↗ |
| Route | Topical | “Optive Fusion® Lubricant Eye Drops (Unit Dose)” NCT06221345 ↗ |